Product Images Duloxetine

This is a description of a medication called DULoxetine. It is a capsule with a dosage of 60 mg and is usually sold in a quantity of 30. The medication is delayed-release, making it more effective over time, and must be kept out of the reach of children. The medicine was manufactured in India by Ajanta Pharma Ltd and repackaged by RemedyRepack Inc. The package insert should be consulted for directions, and the medication should be stored in a cool, dry place between 15-30°C (59-86°F).*

This is a bottle of 30 delayed-release 60mg Duloxetine capsules, manufactured by Ajanta Pharma Ltd. in India. The package is Rx-only and has an NDC number of 70518-1011-01. The medication should be kept out of the reach of children and stored at 20-25°C (88-77°F), with excursions permitted to 15-30°C (59-86°F). The lot number and expiration date are not specified in the text. The package insert should be consulted for usage instructions. The bottle has been repackaged by RemedyRepack Inc. in Indiana, PA.*

DULoxetine is a delayed-release medication with a strength of 60mg per capsule, available in a quantity of 60 capsules. It is a prescription drug that needs to be used only as directed in the package insert. Keep it out of the reach of children and store it at a temperature between 20-25°C (88-77°F), with excursions allowed at 15-30°C (59-86°F) [See USP]. This drug has been repackaged by RemedyRepack Inc., Indiana, PA 15701, 724.465.8762, and should be used by the expiry date mentioned on the package. The Lot Number is not available. The source NDC is 27241-0099-90.*

This data represents a chart showing the treatment response for patients with relapse. The treatments examined are Placebo and Duloxetine, and the chart displays the time in days from randomization to relapse. The x-axis ranges from 0 to 250 and the y-axis ranges from 0.4 to 1.0. No further information is available.*

This is a medication prescription for Duloxetine, which is a drug used to treat depression, anxiety, and pain. The recommended dosage is either 60 milligrams or 120 milligrams per day. The rest of the text appears to be a graph showing the percentage improvement in pain from baseline after taking the medication.*

This is a graph showing the proportion of patients who experienced a relapse over time after randomization to treatment with either a placebo or duloxetine. The x-axis shows time in days from randomization to relapse, and the y-axis shows the proportion of patients experiencing relapse. The graph suggests that treatment with duloxetine may be more effective in preventing relapse compared to placebo.*

The text provides a table with the percentage of patients improved in regards to pain after receiving different doses of Duloxetine and a placebo. The doses mentioned include Duloxetine 60 mg BID, Duloxetine 60 mg QD, and Duloxetine 20 mg QD. The table also lists the percentage improvement in pain from baseline. No further information can be inferred from the text.*

This appears to be a chart or graph showing the percentage of patients who have improved while taking either duloxetine 60mg twice daily or duloxetine 60mg once daily compared to a placebo. The chart also shows the percent improvement in pain from baseline.*

This is a description of a medical treatment that involves taking placebo medication alongside Duloxetine at doses of 60 or 120 mg once daily. There is a table showing a percent improvement in pain from the baseline. Nonetheless, there also appears to be some random and unreadable characters along with a line of text that says "ponoidw) sjualied jo abejusoiad."*

This appears to be a graph or chart showing the percent improvement in pain from baseline after taking a placebo or a dosage of 60mg of duloxetine daily. The X-axis ranges from 0 to 100 and the Y-axis ranges from 0 to 250. However, it is not clear what the specific study or condition being treated is.*